References
- Hendrick AM. Auto-immune haemolytic anaemia - a high-risk disorder for thromboembolism? Hematology 2003; 8(1): 53–56.
- Barker RN, Hall AM, Standen GR, Jones J, Elson CJ. Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia. Blood 1997; 90(7): 2701–2715.
- Ward FJ, Hall AM, Cairns LS et al. Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia. Blood 2008; 111(2): 680–687.
- Allgood JW, Chaplin H Jr., Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med 1967; 43(2): 254–273.
- Standards of medical care in diabetes - 2008. Diabetes Care 2008;31(Suppl 1): S12–54.
- Genuth S, Alberti KG, Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26(11): 3160–3167.
- Muller LM, Gorter KJ, Hak E et al. Increased risk of commoninfections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005; 41(3): 281–288.
- Lang CC, Beniaminovitz A, Edwards N, Mancini DM. Morbidityand mortality in diabetic patients following cardiac transplanta-tion. J Heart Lung Transplant 2003; 22(3): 244–249.
- Livi U, Caforio AL, Grassi G et al. Mid-term results of heart transplantation in diabetic patients. J Cardiovasc Surg (Torino) 1994; 35(6 Suppl 1): 115–118.
- Molad Y, Levin-Iaina N, Vaturi M, Sulkes J, Sagie A. Heart valve calcification in young patients with systemic lupus erythematosus: a window to premature atherosclerotic vascular morbidity and a risk factor for all-cause mortality. Atherosclerosis 2006; 185(2): 406–412.
- Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KY, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52(3): 722–732.
- Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002; 46(9): 2287–2293.
- Blanco FJ, Gomez-Reino JJ, de la Mata J et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 1998; 7(3): 159–163.
- Jacobsen S, Petersen J, Ullman S et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998; 17(6): 478–484.
- Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14(1): 29–34.
- Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341(25): 1906–1912.
- Stegenga ME, van der Crabben SN, Blumer RM et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis dur-ing human endotoxemia. Blood 2008; 112(1): 82–89.
- Leon B, Ardavin C. Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1. Blood 2008; 111(6): 3126–3130.
- McGettrick HM, Hunter K, Moss PA, Buckley CD, Rainger GE, Nash GB. Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration. J Leukoc Biol 2009; 85: 98–107.
- Ou R, Zhang M, Huang L, Flavell RA, Koni PA, Moskophidis D. Regulation of immune response and inflammatory reactions against viral infection by VCAM-1. J Virol 2008; 82(6): 2952–2965.
- Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from type II diabetics exhibit impaired prolifera-tion, adhesion, and incorporation into vascular structures. Circulation 2002; 106(22): 2781–2786.
- Nilsson TK, Sondell KM, Norberg BO, Back O. Plasma levels of endothelial-derived haemostatic factors in autoimmune thrombo-cytopenia and haemolytic anaemia. J Intern Med 1990; 228(3): 249–252.
- Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293(13): 1653–1662.
- Giles FJ, Borthakur G, Ravandi F et al. The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia. Br J Haematol 2007; 136(4): 624–627.
- Sorror ML, Mans MB, Storb R et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106(8): 2912–2919.